CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Haleos Labs Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Haleos Labs Ltd
Plot No:19-III, Road No:71,
Opp. Bharatiya Vidya Bhavan Public Schoo
Phone: +91 406288888p:+91 406288888 HYDERABAD, 500096  India Ticker: HALEOSLABSHALEOSLABS
Business Summary
Haleos Labs Limited is an India-based company. The Company is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with all types of organic & inorganic chemicals, pharmaceuticals, active pharmaceutical ingredients (API) and intermediates. It caters to both domestic and international markets, with its product portfolio comprising established products such as Ranitidine hydrochloride (HCL) and Famotidine, along with other APIs and intermediates. Its products include Ranitidine HCl (Form-2) USP/EP/IP, Famotidine USP/EP/IP, Sildenafil Citrate USP/EP/IP, Allopurinol USP/EP/IP, Ropivacaine HCl USP/EP/IP, Dapsone USP/EP/BP, Sibutramine HCl USP, Itraconazole USP/EP, Fosphenytoin Sodium USP, Domperidone / Domperidone Maleate EP/IP, Tiagabine HCl USP, Albendazole USP/EP/IP, Fosaprepitant Dimeglumine, Hydroxyzine HCl USP/EP/IP, Trazodone HCl USP/EP/IP, and others.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20263/31/2026Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
2869 Industrial organic chemicals, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer N. RajendraPrasad 2/14/2020
Compliance Officer, Company Secretary Trupti R.Mohanty 1/1/2022 2/14/2020
Managing Director, Executive Director Veeravenkata S.Tallurl 62
6 additional Officers and Directors records available in full report.

Business Names
Business Name
540679
HALEOSLABS
SMSLIFE

General Information
Number of Employees: 611 (As of 3/31/2026)
Outstanding Shares: 3,023,287 (As of 3/31/2026)
Shareholders: 6,939
Stock Exchange: NSE


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, October 15, 2026